Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Acta Oncol. 2011 Feb;50(2):233-42. doi: 10.3109/0284186X.2010.535013.
Many patients treated with radiotherapy to the pelvic region report a change in bowel habits. Loose stools, urgency and fecal incontinence may have a significant impact on daily life and social functioning.
We attempted to follow up 789 women, treated with pelvic radiotherapy for a gynecological cancer during 1991 to 2003 at two departments of gynecological oncology in Sweden. A control group of 478 women from the Swedish Population Registry was also included. As a preparatory study, we made in-depth interviews with 26 women previously treated for gynecological cancer. Based on their narratives, we constructed a study-specific questionnaire including 351 questions and validated it face-to-face. The questionnaire covered questions of physical symptoms originating in the pelvis, demographics, psychological and quality of life factors. In relation to bowel symptoms, 60 questions were asked.
Six-hundred and sixteen (78%) gynecological cancer survivors and 344 (72%) control women participated. Two-hundred and twenty-six (37%) cancer survivors reported loose stools at least once a week. Eighty-three percent of the survivors with loose stools every day reported defecation urgency with fecal leakage, compared to 20% of cancer survivors without loose stools. Cancer survivors with loose stools at least once a week were 7.7 times more likely to suffer from defecation urgency with fecal leakage (95% CI 4.4-13.3) compared to those who had loose stools once a month or less. In order to avoid loose stools affected survivors with loose stools often skipped meals (13%), made an active choice of food (47%) and preferentially used prescribed medication (36%).
There is a relation between loose stools and defecation urgency with fecal leakage among long-term gynecological cancer survivors treated with pelvic radiotherapy. Targeting loose stools can possibly help survivors to decrease frequency of fecal leakage.
许多接受盆腔区域放射治疗的患者报告肠道习惯发生变化。腹泻、便急和粪便失禁可能对日常生活和社会功能产生重大影响。
我们试图随访 789 名女性,她们在 1991 年至 2003 年期间在瑞典的两个妇科肿瘤学部门接受盆腔放疗治疗妇科癌症。还纳入了瑞典人口登记处的 478 名对照组女性。作为一项预备研究,我们对 26 名之前接受过妇科癌症治疗的女性进行了深入访谈。根据她们的叙述,我们构建了一个特定于研究的问卷,其中包含 351 个问题,并进行了面对面验证。该问卷涵盖了源自骨盆的身体症状、人口统计学、心理和生活质量因素。与肠道症状相关,共提出了 60 个问题。
616 名(78%)妇科癌症幸存者和 344 名(72%)对照组女性参与了研究。226 名(37%)癌症幸存者每周至少有一次腹泻。每天有稀便的 83%幸存者报告有粪便失禁,而每天无稀便的癌症幸存者为 20%。每周至少有一次稀便的癌症幸存者发生粪便失禁的可能性是每天有稀便的癌症幸存者的 7.7 倍(95%CI 4.4-13.3)。为了避免腹泻,有稀便的幸存者经常不吃餐(13%),主动选择食物(47%),并优先使用处方药物(36%)。
接受盆腔放疗治疗的长期妇科癌症幸存者中,腹泻与粪便失禁便急之间存在关联。针对腹泻可以帮助幸存者减少粪便失禁的频率。